Chronic cough, defined as a cough persisting for more than eight weeks, is a common yet challenging condition faced by clinicians. Despite its prevalence, the diagnosis and management of chronic cough can be complex due to its multifactorial etiology and the need for a comprehensive, patient-centered approach.
Chronic cough is often a symptom of underlying conditions such as asthma, gastroesophageal reflux disease (GERD), and upper airway cough syndrome (UACS). However, in some cases, it may also be idiopathic. Understanding the pathophysiology and conducting a thorough patient history and physical examination are crucial first steps in diagnosis. Laboratory tests, imaging studies, and specialized procedures may also be utilized as needed.
Effective management of chronic cough involves treating the underlying cause, alleviating symptoms, and improving quality of life. Pharmacological interventions, such as bronchodilators, inhaled corticosteroids, and proton pump inhibitors, may be employed depending on the identified cause. Non-pharmacological approaches, including behavioral therapy and physiotherapy, may also be beneficial.
Given the heterogeneous nature of chronic cough, a personalized approach is essential. This involves understanding the patient's unique circumstances, including their medical history, lifestyle, and preferences. A multidisciplinary team involving pulmonologists, gastroenterologists, otolaryngologists, and allied health professionals can provide a comprehensive and coordinated care plan.
In conclusion, chronic cough is a complex condition that requires a comprehensive and personalized approach in clinical practice. By understanding the pathophysiology, conducting a thorough diagnosis, and employing effective management strategies, clinicians can improve patient outcomes and quality of life.
1.
Injecting PD-1 Drug Directly Into Oral Precancers Shrinks Lesions
2.
Sevabertinib Approved for First-Line Mutated NSCLC
3.
After three years, responses to mounetuzumab in follicular lymphoma are still stable.
4.
FDA Bans Red Dye No. 3 From Foods, Ingested Drugs
5.
AI can identify women at risk of breast cancer years in advance: Study
1.
Revolutionizing Cancer Treatment: Advances in Immunotherapy and Cell Therapy
2.
Pediatric Tumor Microenvironment Evolution: Mechanisms, Clinical Impact, and Therapeutic Implications
3.
Hematopoietic Stem Cell Activity Biomarkers in Aging
4.
Bone-Marrow Immune Cell Competition: Mechanisms, Clinical Implications, and Emerging Therapeutic Perspectives
5.
The Truth About TAR Syndrome: Understanding the Rare Genetic Disorder
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII
2.
A New Era in Managing Cancer-Associated Thrombosis
3.
Emerging Concepts in Hematology
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
5.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation